Keywords: wyeth, drops, ptp-112, decided, discontinue, clinical, development

Wyeth drops PTP-112

Article | 17 June 2002

Print This

Wyeth has decided to discontinue clinical development of a candidatedrug for diabetes after it achieved disappointing efficacy in Phase II ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in